Hanssens L - Search Results

1

A Pilot Study of Lung Clearance Index as a Useful Outcome Marker in the Follow-Up of Pediatric Patients with Non-Cystic Fibrosis Bronchiectasis?

Alkoussa W, Hanssens L, Sputael V, De Lucia F, Quentin C. Alkoussa W, et al. Among authors: hanssens l. Children (Basel). 2023 Apr 27;10(5):791. doi: 10.3390/children10050791. Children (Basel). 2023. PMID: 37238339 Free PMC article.

2

[Prevention and treatment of asthma in child].

Hanssens LS, Mulier SF. Hanssens LS, et al. J Pharm Belg. 2007;62(1):33-7. J Pharm Belg. 2007. PMID: 17508666 Review. French.

3

Mounier Kuhn syndrome presenting with recurrent atelectasis.

Quentin C, Lefevre N, Bodart E, Hanssens L. Quentin C, et al. Among authors: hanssens l. Acta Clin Belg. 2018 Jun;73(3):233-235. doi: 10.1080/17843286.2017.1373498. Epub 2017 Sep 11. Acta Clin Belg. 2018. PMID: 28891754

4

A case report of successful eradication of new isolates of Burkholderia cenocepacia in a child with cystic fibrosis.

Sputael V, Van Schandevyl G, Hanssens L. Sputael V, et al. Among authors: hanssens l. Acta Clin Belg. 2020 Dec;75(6):421-423. doi: 10.1080/17843286.2019.1630585. Epub 2019 Jun 15. Acta Clin Belg. 2020. PMID: 31204617

5

Immunoglobulin G: A useful outcome marker in the follow-up of cystic fibrosis patients?

Hanssens LS, Cellauro S, Duchateau J, Casimir GJ. Hanssens LS, et al. Immun Inflamm Dis. 2021 Jun;9(2):608-614. doi: 10.1002/iid3.426. Epub 2021 Mar 30. Immun Inflamm Dis. 2021. PMID: 33783131 Free PMC article.

6

"Just Move It . . . Move It": A Multidisciplinary Motivational Approach to Improve Physical Activity in Children With Cystic Fibrosis.

Sputael V, Gaspar V, Weber V, Soussi K, Knoop C, Hanssens L. Sputael V, et al. Among authors: hanssens l. Glob Pediatr Health. 2023 Mar 6;10:2333794X221150728. doi: 10.1177/2333794X221150728. eCollection 2023. Glob Pediatr Health. 2023. PMID: 36911754 Free PMC article.

7

Four-year evaluation of neonatal cystic fibrosis screening in Southern Belgium.

Thimmesch M, Berardis S, Hanssens L, Quentin C, Boemer F, Luis G, Dewulf JP, Marie S, Marcelis L, Lefèvre N, Libioulle C, Dideberg V, Philippeau M, Revencu N, Boboli H. Thimmesch M, et al. Among authors: hanssens l. Eur J Pediatr. 2024 Nov 21;184(1):38. doi: 10.1007/s00431-024-05845-4. Eur J Pediatr. 2024. PMID: 39570414

8

The clinical benefits of long-term supplementation with omega-3 fatty acids in cystic fibrosis patients - A pilot study.

Hanssens L, Thiébaut I, Lefèvre N, Malfroot A, Knoop C, Duchateau J, Casimir G. Hanssens L, et al. Prostaglandins Leukot Essent Fatty Acids. 2016 May;108:45-50. doi: 10.1016/j.plefa.2016.03.014. Epub 2016 Mar 28. Prostaglandins Leukot Essent Fatty Acids. 2016. PMID: 27154364 Clinical Trial.

9

[Impact of the transition period from childhood to adulthood in cystic fibrosis].

Louagé A, Knoop C, Hanssens L. Louagé A, et al. Among authors: hanssens l. Rev Mal Respir. 2020 Mar;37(3):235-242. doi: 10.1016/j.rmr.2019.11.650. Epub 2020 Jan 16. Rev Mal Respir. 2020. PMID: 31955962 French.

10

Influence of lung transplantation on the essential fatty acid profile in cystic fibrosis.

Hanssens L, Duchateau J, Namane SA, Malfroot A, Knoop C, Casimir G. Hanssens L, et al. Prostaglandins Leukot Essent Fatty Acids. 2020 Jul;158:102060. doi: 10.1016/j.plefa.2020.102060. Epub 2020 Jan 23. Prostaglandins Leukot Essent Fatty Acids. 2020. PMID: 32044180

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters